Skip to main content
Contact Us
Subscribe
E-Edition
61°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
ReShape Lifesciences, Inc. - Common Stock
(NQ:
RSLS
)
0.6350
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ReShape Lifesciences, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Why Is Genetic Technologies (GENE) Stock Up 173% Today?
February 03, 2023
Genetic Technologies (GENE) stock is taking off on Friday as the company prepares for new cancer test areas with a collaboration.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 03, 2023
Via
Benzinga
Why Is Reshape Lifesciences (RSLS) Stock Up 136% Today?
February 03, 2023
Reshape Lifesciences (RSLS) stock is rocketing higher on Friday as a filing mixup shines a light on the company's shares.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
February 03, 2023
Good morning! It's time to start the final day of trading this week with a look at the biggest pre-market stock movers for Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
January 23, 2023
Via
Benzinga
Reshape Lifesciences Earnings Perspective: Return On Capital Employed
December 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 13, 2023
Via
Benzinga
Exclusive: 5 Stocks To Watch From Benzinga Moneymaker Index, One Large Cap And 4 Small Cap Names
January 05, 2023
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities.
Via
Benzinga
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 04, 2023
Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 04, 2023
Via
Benzinga
Looking Into Reshape Lifesciences's Recent Short Interest
January 04, 2023
Reshape Lifesciences's (NASDAQ:RSLS) short percent of float has risen 25.0% since its last report. The company recently reported that it has 2 thousand shares sold short, which is 0.5% of all regular...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 04, 2023
Via
Benzinga
Why Oblong Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket
January 04, 2023
Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares rose 63.2% to $0.4201 in pre-market trading after dropping 8% on Tuesday. Elys Game Technology and Cloakbook were recently granted a license to...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 04, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
Via
InvestorPlace
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 03, 2023
Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 03, 2023
Via
Benzinga
Wall Street Starts 2023 On Positive Note
January 03, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 29, 2022
Via
Benzinga
ReShape Lifesciences Announces 1-for-50 Reverse Stock Split Effective as of Commencement of Trading on December 23, 2022
December 22, 2022
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 15, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 29, 2022
On Tuesday, 89 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 20, 2022
On Tuesday, 298 companies achieved new lows for the year.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 16, 2022
Via
Benzinga
ReShape Lifesciences(TM) (NASDAQ: RSLS) Featured in Coverage of Investor Summit Group’s Q4 Event
November 15, 2022
Via
Investor Brand Network
ReShape Lifesciences™ Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
Conference Call to be Held at 8:00 am ET Today
From
ReShape Lifesciences Inc
Via
GlobeNewswire
Earnings Scheduled For November 14, 2022
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
ReShape Lifesciences Announces $750,000 Registered Direct Offering
November 08, 2022
From
ReShape Lifesciences Inc
Via
GlobeNewswire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.